Drugsinus's Blog

Posts Tagged ‘people

Clot risk jumps on long flights

Posted by: drugsinus on: January 17, 2010

The risk of venous thromboembolism, a rare but potentially deadly clot-forming condition, is three times greater for travelers than for people who are not cramped for many hours in airplanes or on other forms of transportation, says one of the first studies to measure the risk. The report Monday in the Annals of Internal Medicine [...]

Positive family history worsens depression: study

Posted by: drugsinus on: January 17, 2010

HONG KONG () – People with a family history of depression, anxiety and alcohol and drug dependence are not only likely to develop these conditions, but tend to suffer more seriously and need more treatment, a study has found. In the nearly 30-year study in New Zealand, researchers tracked 981 people from the time they [...]

Tags:

Pro-marijuana ad pushes pot as budget fix

Posted by: drugsinus on: January 17, 2010

SAN FRANCISCO — A pro-marijuana group is launching another television bid to legalize pot in California — this time with the pitch that legalizing and taxing the drug could help solve the state’s massive budget deficit. The 30-second ad, airing Wednesday and paid for by the Marijuana Policy Project, features a retired 58-year-old state worker [...]

Drug helps monkeys, rabbits survive anthrax

Posted by: drugsinus on: January 17, 2010

By Julie Steenhuysen CHICAGO () – An experimental antibody treatment helped rabbits and monkeys survive a deadly dose of anthrax bacteria and proved safe in humans, too, researchers at Human Genome Sciences said on Wednesday. The treatment, ABthrax or raxibacumab, works by preventing toxins produced by anthrax bacteria from causing cell damage and death. It [...]

Tags: ,

Roche’s Avastin drug shrinks ear-nerve tumors

Posted by: drugsinus on: January 17, 2010

By Gene Emery BOSTON () – Avastin, a widely used cancer drug made by Roche AG, shrank tumors growing along the nerves leading to the ears, improving the hearing of patients with a rare tumor, researchers reported on Wednesday. The findings suggest that Avastin, already used to restrict the flow of blood to advanced colon [...]

Study: Overweight people gain more when stressed by work

Posted by: drugsinus on: January 17, 2010

If you find yourself wolfing down a bag of chips or a package of cookies after a bad day at the office, here’s some news that might interest you: Overweight men and women tend to pack on pounds from job stress and financial pressures, a study shows. Researchers analyzed national data on 1,355 men and [...]

Ebola in pigs may become more dangerous for people: experts

Posted by: drugsinus on: January 17, 2010

HONG KONG () – Researchers are worried about a type of Ebola virus spreading in pigs in the Philippines and have warned that it could mutate in the swine population and become more dangerous for people. The Philippines had tested 141 people, the researchers said, and six of them who either worked on pig farms [...]

Monkeys live longer on low-cal diet; would humans?

Posted by: drugsinus on: January 17, 2010

WASHINGTON (AP) — Eat less, live longer? It seems to work for monkeys: A 20-year study found cutting calories by almost a third slowed their aging and fended off death. This is not about a quick diet to shed a few pounds. Scientists have long known they could increase the lifespan of mice and more [...]

Tags: ,

Scientists, public differ in outlooks

Posted by: drugsinus on: January 17, 2010

Scientists and the public don’t see eye-to-eye on animal research, evolution or moneymaking, finds a poll out Thursday, but both agree on one thing. They like science. In the Pew Research Center survey, 84% of non-scientists say science has a “mostly positive effect on our society,” and 76% of scientists say these are “good times” [...]

Bayer says Alzheimer test shown to work in study

Posted by: drugsinus on: January 17, 2010

FRANKFURT () – Bayer’s Alzheimer’s disease (AD) marker florbetaben was shown to help detect the illness in eight out of 10 cases in a Phase II study, possibly offering a way to diagnose early onset. “(Bayer aims to) contribute to diagnosing AD in the future more precisely and at an earlier time during the course [...]

Tags:

Follow

Get every new post delivered to your Inbox.